AWARDS AND ACHIEVEMENTS
Spices Board Excellency Award for Curegarden's parent company, Arjuna Natural Extracts Ltd.
Arjuna natural extract has been selected for the Excellency award by the Spices Board in recognition of the outstanding performance in the export of spices and spice products for the year 2012-13 and 2013-14. Mr. Jomy, Director, marketing took home the recognition Top Most Exporter of New Spice Product for 2012-13 on behalf of Arjuna. The entire Arjuna family is in joy and ecstasy. “We are constantly trying to innovate on spice products to cater to the changing needs of the consumers,” says Mr. Jomy.
Study Shows Turmeric Can Reduce Symptoms of Depression and Anxiety
Arjuna Natural Extracts is targeting the European market with its BCM-95 Curcumin, an all-natural patented formulation of turmeric extract. This ingredient can help mitigate symptoms of depression and anxiety, according to a recent clinical study, further backed by nearly two dozen previous studies supporting the health benefits of BCM-95 Curcumin extract. The randomized, double-blind, placebo-controlled study of 56 individuals with major depressive disorder was published in June, 2014 by Adrian Lopresti, PhD, et al., of Murdoch University, Australia, in the peer-reviewed Journal of Affective Disorders 167(2014)368–375. Results showed that supplementation with BCM-95 Curcumin succeeded in reducing the overall symptoms of depression, functioning as an anxiolytic as well when taken over a period of 8 weeks. Greater efficacy from curcumin treatment was identified in a subgroup of individuals with atypical depression (common depression). There were no significant differences in the adverse events between BCM-95 and the placebo. “Curcumin’s positive antidepressant and anti-anxiety effects are likely due to its ability to normalize specific physiological pathways,” says Lopresti. “It appears to elevate neurotransmitters such as serotonin, while lowering stress hormones, such as cortisol, and is a potent antioxidant and anti-inflammatory. Curcumin also provides protection to the brain.” Another important mechanism via which curcumin is thought to alleviate symptoms of depression is via its’ potent anti-inflammatory effects. Depression is increasingly believed to be an inflammatory condition, with the inflammatory chemicals being responsible for the symptoms. Depression is a common, treatable disorder that continues to remain under detected globally. Health surveys indicate that major depression is experienced by 10-15% of people in their lifetime. Depression is caused by multiple factors and the success rate of current treatment is only 20-40%. Many treatments are associated with side effects from long-term use, including anxiety, thoughts of suicide, insomnia, weight gain and sexual dysfunction. Curcumin works simultaneously on multiple pathways associated with depression. It is considered as the most promising therapeutic targets to treat depressive behavior. BCM-95 curcumin is produced from non-GMO turmeric. It has been extensively researched by universities throughout the US, Australia, Japan and India in multiple clinical studies and has attained 12 international patents. BCM- 95 curcumin is manufactured by synergistically combining curcumin and essential oil of turmeric, without synthetic additives. The therapeutic benefits of turmeric can be attained at its best by combining curcumin with ar-turmerone, an active compound derived from essential oil of turmeric. In BCM-95, this unique synergy forms a 95% bioactivity enhanced curcuminoid complex to create a highly bioactive turmeric extract with superior bioavailability. Arjuna’s production processes and products meet market-specific regulations worldwide. A GMP-certified, SAP-driven company, Arjuna has achieved international certifications including ISO22000, Kosher and Halal. Arjuna continues to engage in research and development, with continuing scientific validation of its novel product line through advanced clinical studies. (The article was originally published in Nutrition Insight) http://www.nutritioninsight.com/news/Study-Shows-Turmeric-Can-Reduce-Symptoms-of-Depression-and-Anxiety.html?tracking=Search+Results+-+Articles+On+NutritionInsight&type=News
Arjuna takes curcumin to the next level
Arjuna Natural Extracts reports increasing sales of its leading brand, BCM-95 curcumin. Sales of the all-natural, patented formulation of turmeric extract rose globally by 20% in 2015 compared with 2014. Google points to turmeric as a 'rising star' — ranked by volume of searches — in its food trends report for 2016. The interest in this functional ingredient grew by 56% from November to January this year alone. Consumers are turning to YouTube to learn about the benefits of turmeric — so much so that the top five educational videos on turmeric attracted a total nearly 4 million views. DolCas Biotech, the US associate of Arjuna Natural Extracts, plays a significant role in steering the extensive research initiatives on curcumin, jointly funded by both the companies. 'Consumers already trust this ingredient and brand, and growing awareness of the health benefits of turmeric extracts spurred an increase in sales of BCM-95 of 20%,' explains Jomy Jose, Marketing Director for Arjuna. 'We also increased the production capacity by 20% to match this growing demand for BCM-95,' Jose notes, adding: 'While consumers are actively seeking information on turmeric, there is confusion in the market about curcumin absorption and oral bioavailability, Also, unsubstantiated claims by various 'rush-to-market' copycat turmeric products contributes to consumer insecurity.' The main problem of curcumin is that it is not absorbed nor retained well in the blood. Many curcumin products add synthetic additives to solve this problem. Such additives can have a negative impact on the active ingredients’ purity and potency. In the cases of unregulated turmeric products, the additives themselves, as well as purity problems in general, could lead to potential health issues with long-term use. 'Any supplement you put into your body should be both safe and effective,' insists Benny Antony, PhD, Joint Managing Director for Arjuna. 'Arjuna’s curcumin is highly bioavailable thanks to the synergism between the curcumin and the compound ar-turmerone, an essential oil component of turmeric extract. Ar-turmerone concentrates in BCM95 synergistically combine with curcuminoids to reach the blood stream in unmodified — and thus more bioactive — form.' The turmeric used for BCM-95 eliminates the chance of contamination. BCM-95 does not contain any pesticides and complies with the standards set by EU regulations. It also meets the new European 2015/1933 PAH regulation that sets maximum levels of PAHs in food supplements. 'There is a gap between consumer desire to use good-for-you curcumin and the offerings in the market,' adds Jose. 'This makes it harder for processors to develop a new supplement or functional food or beverage,' submits Jose. 'Arjuna has the expertise and technical staff to help product developers fill this gap. (The news was originally published in Nutraceutical Business Review) http://www.nutraceuticalbusinessreview.com/news/article_page/Arjuna_takes_curcumin_to_the_next_level/119774
Export Excellency Award - FIEO for Arjuna Natural Extracts Ltd.
Yet another proud moment beckons Arjuna Natural Extracts Ltd ( Parent company of CUREGARDEN) with the company bagging the Southern Region ‘Export Excellency Award’ instituted by Federation of Indian Export Organizations (FIEO) for the year 2013-14. The award recognizes excellence in export performances by exporters based in Southern Region. The award committee comprised of leading member of FIEO, Financial Institutions and Senior Central and State Governments Officials. The jury laid equal emphasis on firms who have made extra efforts to diversify to emerging markets as well as including new products and services in their list of offerings. Mr. P.J Kunjachan (Chairman & Managing Director) received the award from Smt. Nirmala Sitharaman , Hon’ble Union Minister for Commerce and Industry on October 8th,2016 in Chennai
Arjuna Natural Extracts receives ‘Exporter of the year’ award!
The Kerala-based Arjuna Natural Extracts has been recognized as the ‘Most Innovative Exporter Award’ at the ECGC – D&B Indian Exporters Excellence awards 2015. The award is to recognise the contribution of exporters to the Indian economy. Mr P.J.Kunjachan, Chairman and Managing Director received the award from Nirmala Sitharaman, Union Minister of State for Commerce and Industry at a function held recently in Mumbai. Arjuna Natural Extracts was in news for receiving a US patent for the treatment of Alzheimer’s disease. The company has recently launched world’s first nitrate extract from Red Spinach. (This article was published in The Hindu Business Line on March 10th 2015.)
Arjuna Natural Extracts opens office in Brussels
Leading manufacturer of botanical extracts, Arjuna Natural Extracts is all set to strengthen its presence in the European market with a new operational base in Brussels, Belgium. The company known for its patented turmeric extract BCM-95 has customers across 40 countries globally. BCM-95 had recently acquired a patent on the method of treatment of Alzheimer's disease. "The preventive healthcare market is gaining momentum in Europe and companies backed by extensive research and quality centric regime will find the market promising" said P.J Kunjachan, managing director of Arjuna Natural Extracts, which has a turnover of Rs 200 crore. Arjuna invests more than 10% of its turnover towards R&D driven initiatives annually and is associated with several international universities for undertaking clinical trials and studies. The company complies with complies with the new European regulations. . "We have invested in top quality control equipment to meet the new European regulations. The growing demand of nutraceutical products in the global market and the consumers' expectations to get a pure formula, encourage us to develop a clean, GMO-free ingredient that the consumers can trust" said Dr Benny Antony, joint managing director of Arjuna. In connection with the new expansion plans the company was recently visited by the Belgium consul- general, Dr. Bart De Groof at its manufacturing facility in Coimbatore. (The news was originally published in The Economic Times on January 29, 2016) http://economictimes.indiatimes.com/industry/indl-goods/svs/chem-/-fertilisers/arjuna-natural-extracts-opens-office-in-brussels/articleshow/50769203.cms >
Arjuna Natural Extracts gets US patent on turmeric formulation
In a significant development for Kerala-based Arjuna Natural Extracts Ltd, it has received a patent in the United States on BCM-95, a turmeric extract formulation that could be used to target Alzheimer’s disease. Explaining the application patent, Benny Antony, Joint Managing Director of the company said, the product is a re-blend of two ingredients in turmeric, but in a ratio that is not seen in naturally occurring turmeric. It is a reblend of curcuminoid and an essential oil of turmeric, he said. India has in the past blocked efforts to patent naturally occurring turmeric and tulsi (basil) etc, and has even set up a digital traditional library to document known uses of these products. And the reason for that is because a patent gives the patent-holder a monopoly on the sale and manufacture of the product for a fixed period of time. The BCM-95 product works as a preventive, Antony says, as it targets ß-amyloid, that is seen in large quantities in people with Alzheimer’s and is seen as one of the reasons for the disease. BCM9 – a mixture of curcumin, the yellow colouring substance of turmeric and an essential oil from the spice – is already available in India. But it is sold as a supplement and does not make therapeutic claims. The product has been peer-reviewed and is also being studied for various indications including arthritis, diabetes, depression, cancer prevention and treatment, adjutant with chemotherapy and cancer radiation, liver and gastro intestinal diseases etc, company officials said. He said that the product has already undergone human clinical trials in patients with Alzheimer’s disease at Chinese University of Hong Kong and has found to be highly beneficial in arresting the progress of the disease. It is also undergoing two other human clinical trials in patients with Alzheimer’s disease and subjects at risk of developing Alzheimer’s disease in Australia. According to him, there are several curcumin based products in the market now and BCM-95 ranks among the top selling products. The company is awaiting a European patent for the product. The Department of Biotechnology in India had sanctioned around ₹14 crore for a clinical study of BCM95 in the treatment of mouth cancer. The company, a leading domestic manufacturer and exporter of botanical extracts, also applied for patent for the uses of amla extracts for reducing cholesterol, pomegranate extracts for treating heart disease and extracts of Boswsellia Serrata (Indian Frankincense) for prevention of arthritis and inflammation. (This article was published on November 24, 2014 in, The Hindu BusinessLine and Economic Times in Hyderabad, Kochi and Bangalore) >
Meet one of India’s finest entrepreneurs P.J Kunjachan, who has not only won several awards but has also taken India’s reputation in the extraction business several notches higher!
Hear from the trendsetter himself, P.J Kunjachan the man who started one of India’s best Nutraceuticals company today, talks about the latest trends in India and abroad in the supplement market. He talks about, how young Indians today are very aware of the harmful effects of the pharma drugs and at the same time are understanding the goodness and therapeutic value of natural plant extracts whether fruits or the entire plant. Mr. Kunjachan points out the importance of having a good R&D wing, which is a must for all the nutraceutical companies. Arjuna’s R & D and innovation is what sets them apart from the their competitors. Please find the entire interview here. http://arjunanatural.com/media/images/medaicoverage-img/MD%20Interview-%20NuffooDs%20Spectrum.pdf >?
Turmeric enters the realm of chronic disease management!
Turmeric has long been known to have healing properties; however, more and more research emerges to prove its efficacy in the management of cancer and depression. >
Kerala Agriculture University grants 60 lakhs to Arjuna for product development using ginger’s active ingredient.
While ginger is a pharmacologically important component in ginger, ginger has a slow content of gingerol. Curegarden parent company, Arjuna Natural Extract has been commissioned to develop high concentrate of gingerol extract through their scientific stabilization and purifying methods. The Kerala Agricultural University (KAU) has launched a project on Public-Private Partnership (PPP) mode.It has signed a memorandum of understanding with private sector Arjuna Natural Extracts Limited for a project, ‘Metabolome analysis in ginger and product development using gingerol’. Industrial feasibility KAU Vice Chancellor P. Rajendran said the project was intended to take research findings to the industry. “Ginger has been used from time immemorial for therapeutic use. The KAU has developed several ginger varieties having high gingerol content. Gingerol being a pharmacologically important component in ginger with anti-inflammatory, analgesic, antipyretic, gastro-protective, cardiotonic and anti-hepatotoxic qualities, these KAU varieties are very useful in development of medicines with organic base,” he added. T.R. Gopalakrishnan, Director of Research, said the project proposed under the PPP mode was funded by the Biotechnology Industry Research Council of the Union Department of Biotechnology. The project will be jointly implemented by the Centre for Plant Biotechnology and Molecular Biology of KAU and the Arjuna Natural Extracts Limited, an ISO 9001 and 2200 Company. The duration of the project is expected to be three years. The total outlay was Rs.14.8 crore, he said. Benny Antony, Founder Director, Arjuna Natural Extracts Limited, said that gingerol content was a vital parameter in production of ginger-based medicinal preparations, but its international market remained largely untapped because of the low gingerol content in traditional cultivars and poor gingerol stability issues. “The novel ginger cultivars of KAU with high gingerol content will help commercialise quality guaranteed stable ginger extract by developing a ginger extract powder with at least 6 per cent gingerol content. The project will develop methods to increase the stability of gingerols in the product, identify and purify individual gingerols, and establish the safety of the standardised ginger extract. We had earlier collaborated with research institutions in the U.S. and Australia,” he added. ‘Boon to farmers’ M.R. Shylaja, professor, who detected the industrial feasibility of new ginger varieties with high gingerol content developed by her, said this project would be a boon to ginger farmers as it would lead to ensuring buy-back guarantee at fair price. >
Curegarden to launch ‘Rhulief balm’ – a unique patented formulation which helps relieve pain, arrests inflammation, and prevents joint degradation.
Curegarden launches a natural pain relieving balm which not only relieves pain but also stops joints from further degradation. Curegarden has used Boswellia Serrata, in the formulation along with the essential oil of Boswellia. Boswellia is a tree gum resin that has multiple health benefits. Also known as Indian frankincense, it has been burned as incense in religious and cultural ceremonies for centuries. Boswellia is widely regarded as a potent anti-inflammatory nutrient, wherein its primary active ingredient, acetyl-11-keto-β-boswellic acid (AKBA), inhibits the inflammatory enzyme 5-lipoxygenase. Rhulief balm contains the potent extract of the botanic Boswellia Serrata, blended with the essential oil of Boswellia to relieve pain and inflammation to prevent further joint damage. Boswellia, with its unique lipo oxygenase (LOX) inhibitory action, not only relieves pain, but arrests underlying inflammation to protect the joint from further damage. What sets this balm apart from all the other balms in the market are two unique properties of boswellia; it stop further degradation of joints due to its anti-inflammatory properties and unlike all the NSAID’s in the market, Rhulief works on both pain pathways(COX,LOX), so it stops pain and relieves inflammation. The balm is all set to launch next month in Bangalore, it will be available online across India. >
Directorate of Industries & Commerce MSME award presented to Arjuna Natural Extracts Ltd
Thiruvananthapuram 20.02.14: India’s leading herbal extraction company Arjuna Natural Extracts Ltd has been bestowed with Directorate of Industries and Commerce’ MSME (Micro Small & Medium Enterprises) Award’ 2011-12 for Ernakulam district on February 20, 2014 at Thiruvanthapuram. The award was presented by Shri.P.K. Kunhalikutty, Minister for Industries and Information Technology to Mr. P.J Kunjachan (Managing Director- Arjuna Natural Extracts Ltd) at a function held on 20-02-14 at Thiruvanthapuram. The award recognizes outstanding performances exhibited by companies from districts of Kerala during the year. Expressing his happiness on the receipt of the award, Mr. P.J. Kunjachan said “An award of such repute motivates us to continue laying our focus on research and innovation. Behind this success is our people’s unflinching dedication and commitment. I extend my heartfelt gratitude to each one of them”. Arjuna Naural Extracts Ltd, headquartered at Aluva, is India’s leading company specialized in the field of scientific methods of identification, separation and manufacturing of plant based active compounds. Arjuna caters to a customer base that spans over 40 countries across the globe and has been acquired 18 international patents to its credit. The company has been known for its relentless focus on research and innovation since its inception and owns an exclusive R& D division approved by Ministry of Science & Technology, Government of India since 2002. Arjuna was recognized previously by KSIDC (Kerala State Industrial Development Corporation) and Spices Board of India with an award of excellence for outstanding entrepreneurial initiatives. Arjuna’s flagship product BCM-95 is a 100 percent standardized extract of turmeric and patented formulation of Curcumin. Curcumin is a bio- active component of turmeric and has proven antioxidant, anti- inflammatory and anti- cancerous properties. Currently, BCM- 95 is the world’s largest selling bio-available turmeric extract. The company also has a fleet of other herbal extracts including Ginger Extract, Garcinia Cambogia Extract, Green Tea Extract, Red Spinach Extract, Mustard oil and Omega-3 oil to name a few.>
Curegarden launches in Bangalore
Bangalore, May 22, 2013: Curegarden, a subsidiary of Arjuna Natural Extracts Ltd (ANEL), India’s leading exporter of high grade botanical extracts, announced the arrival of their products in Bangalore. The company unveiled their revolutionary, patented ingredient BCM-95™, a 100 percent standardized extract of curcumin, the most active compound of turmeric. The launch event announced the arrival of three Curegarden products — Natural Joint Rescue, Natural Diabetes Defense and Natural Daily Defense. Speaking on the occasion, Mr. P.J. Kunjachan, Chairman and MD, Arjuna Natural, said, “BCM- 95™ is a revolutionary solution for inflammatory diseases. With Curegarden products now in Bangalore, we will be reaching out to our customers directly." Dr. Benny Antony, Director Technical, Arjuna Natural, said, “With proven scientific expertise and technology, Curegarden is all set to explore the wonders of one of the most powerful botanical extracts in the world. We are pleased with the six US patents and a patent from Japan that BCM-95™ has received; the European patent is pending. We look forward to expansion to Mumbai and Chennai markets within the year.” Curegarden products are available in 35 outlets (that includes organic product selling outlets as well as pharmaceutical stores). >
P.J. Kunjachan, a model entrepreneur with a modest beginning
A case study on Entrepreneur Development and Small Business Enterprises for an MBA course offered by Indira Gandhi National Open University lists three names as examples. The first two are anybody’s guess: Dhirubhai Ambani and Karsanbhai Patel. The third person is from Kerala, a place not exactly known for entrepreneurship. In fact, P.J. Kunjachan, the Managing Director of Arjuna Natural Extracts Limited (ANEL), who was cited as a model entrepreneur, was surprised at the inclusion of his name. “I came to know about it only when somebody showed it to me. They had not even contacted me,” Kunjachan said. He may not be known so well outside the world of spice extracts. The study describes him as a successful model entrepreneur, who started his career as a proofreader with a local vernacular daily and as a newspaper vendor, and rose to head a company targeting a turnover of Rs 100 crore this year. ANEL is the largest manufacturer of Omega-3 fatty acids from fish oil in Asia and is now the producer of the world’s largest selling bio-available turmeric extract BCM-95™. BCM-95™, developed by ANEL scientists, is sold as an antioxidant and has obtained six patents from the US and one from Japan; the European patent is pending. ANEL has bagged 11 international patents in all. Perhaps what sets Kunjachan apart from other entrepreneurs from Kerala, is his willingness to do something different for which he is prepared to spend time, money and effort. The discovery of Omega-3 fatty acids 10 years ago was the first milestone that gave the company a name. The man who earned his spurs as a fragrant spice extractor began ironically with a nasty smelling substance. He set up a unit for producing bone meal from crushed bones to be used as organic manure. A thriving bone meal business led to a turning point. With the inspiration of his brother-in-law biochemist Dr. Benny Antony and brother Paul, he set up ANEL 20 years ago to export spice extracts. He then faced a series of challenges — first of which was the mopping up of resources because no bank was willing to fund the project. They pooled in Rs 3 lakh to begin operations. They developed essential oil from mustard, an innovative product at that time. Though it was tough to export it to the US because it had been classified as hazardous, it was a runaway success. The first year saw them making a turnover of Rs 70 lakh with a profit of Rs 45 lakh. He enjoyed a stroke of luck in the form of rupee devaluation and the export income began to pour in. Banks started chasing him after this success. The state tax department slapped a penalty for nonpayment of tax. But Kunjachan won an appeal against it because export turnover was not taxable then. The company hit the jackpot when it identified and separated Omega-3 fatty acids, a good source of antioxidants, from sardine oil. It is sold to big pharmaceutical companies who made products based on them. ANEL later shifted its focus to research when it found that competition was tough in spice extract exports. While many companies spend 3-5 percent of their income on research, ANEL devotes 12 percent of its proceeds on development. Kunjachan admits it was a challenge to identify the molecule that enhances bio-availability of curcumin in the body. BCM-95™ is seven times more bio-available than any other curcumin extract. It is unique because the extract is a reconstituted one, meaning it does not use foreign molecules. Today, the company employs 300 people. It has a production unit in Kerala and two in Tamil Nadu and it plans to convert a closed factory in Kerala into an R&D lab. Its two subsidiaries, Livlong Nutraceuticals and Herbal Supplements, cater to foreign markets. Kunjachan says the real architect of the company’s success story is his brother-in-law Dr. Benny Antony, who has inspired the staff to develop new products. “As an entrepreneur, one should always dream of success. Yes, problems will be there but every problem has a solution,” and that Kunjachan says, is his success mantra. This article first appeared in The Economic Times. >
Dr. Benny wins Innovator of the Year award
Dr. Benny Antony, Technical Director of Arjuna Natural Extracts Limited has been awarded with Innovator of the Year award for 2012 by the Spices Board of India. He was honoured with this award for his effort in inventing ANEL’s own bio-available turmeric extract, BCM-95™. BCM-95™ gained worldwide popularity within a short span of time. This highly bio-available curcumin extract has proven to be beneficial in inflammatory conditions such as arthritis, diabetes, heart disease, Alzheimer’s and cancer. BCM-95™ has been commercially successful with proven efficacy to be the best available curcumin extract with the highest bio-availability. >
Outstanding entrepreneurship and patent awards for Arjuna Natural
On the Golden Jubilee celebration of Kerala State Industrial Development Corporation (KSIDC), P. J. Kunjachan, Managing Director of Arjuna Natural Extracts Limited received the “Outstanding Entrepreneurship Award” from the honourable Chief Minister of Kerala, Oommen Chandy at Le Meridien Hotel, Cochin, on July 30, 2011. Arjuna Natural has developed an indigenous technology to increase the bio-availability of oral curcumin by combining with essential oil of turmeric, for which the company received a US patent (Patent No: US 7,736,679 B2). The proprietary formulation of bio-available curcumin is marketed worldwide as BCM-95™. Arjuna Natural Extracts Ltd (ANEL) is India’s leading company specialized in scientific methods of identification, separation and manufacturing of plant-based active compounds and Omega 3 fatty acids from marine and vegetable sources. ANEL also focuses on pharmacological evaluation of its products by design, monitoring and publishing of clinical studies for various applications in the dietary supplement, pharmaceutical, and cosmetic industries. >
Arjuna Natural launches initiative to ‘go green’
A decade after the establishment of its facility at Karumathampatti on the outskirts of Coimbatore, Arjuna Natural Extracts Limited (ANEL) has not only firmed up its operations, but also seems serious about its ‘go green’ initiative. The company has tied up with Tata Solar for erecting a 250 kw unit. P.J. Kunjachan, Chairman and Managing Director of Arjuna Natural Extracts said the unit consumed solar power for manufacturing purposes. ‘We put up a small (14 kw) solar unit two years back. As we scaled up our operations, we decided to go for a bigger unit,’ he said, referring to the 250 kw plant. The company has invested around Rs 2.5 crore on this solar plant. “Our first unit was established at Kochi in Kerala in 1989. Today, this is the R&D hub for Arjuna Natural Extracts. We have since established two more facilities outside our home state Kerala, at Sathyamangalam near Erode and Karumathampatti near Coimbatore in Tamil Nadu. We have over 300 persons on our rolls at present (all units put together),” Mr Kunjachan added. The company is into identification and separation of plant-based compounds and Omega 3 fatty acids from marine and vegetable sources. It has 11 international patents to its credit, and is a leading manufacturer of amla, pomegranate, thulasi and turmeric extract. Currently, ANEL is focusing on 32 products including four natural anti-diabetic products, said Mr Kunjachan. The company exports more than 60 percent of its extracts to the US, UK and Far East. “The journey till date has been a roller coaster ride with ups and downs in its way. The future looks good though,” he said. Find the original article here. >
Arjuna Natural receives GMP certification
Arjuna Natural Extracts Limited has received the GMP (Good Manufacturing Practices) certificate as per Food Codex for its Coimbatore and Edayar (Cochin) manufacturing units from Bureau Veritas Certification (India) Private Limited. The Edayar plant received the certificate for the manufacture of standardized herbal and spice extracts and the Coimbatore plant for the manufacture of standardized herbal and spice extracts, and omega-3 fatty acid concentrates. A press conference along with a certificate handover ceremony was held on February 13, 2013 at Jenny Club, Coimbatore. R.K. Sharma, Director, Indian Operations of Bureau Veritas Group, along with the media, vendors and partners, and staff of Arjuna were part of this occasion.
Arjuna Natural’s new plant at Cochin
A new extraction unit has been inaugurated at Cochin right next to Arjuna Natural’s R&D Laboratory, adhering to GMP (Good Manufacturing Practices) standards right from its construction. The laboratory is spread across an area of 4500 square metres, with clean air circulation, and per day production and raw material handling capacity of 6-8 tonnes. The plant is designed to minimize the consumption of energy and also to maximize utilization of the consuming energy. The wastes generated during the production processes are completely used as fuel for running the boiler; thereby preventing pollution of the environment through efficient waste disposal. Since the waste is completely organic in nature, its disposal does not pollute the atmosphere. The new Arjuna plant is one of the best herbal extraction units in India. It is equipped with highly efficient modern technology such as Batch Extractors and Product Dryers>
Australian High Commissioner visits Arjuna plant
The High Commissioner of Australia, Peter Varghese and his team visited Arjuna Natural’s Edayar plant on September 13, 2012. The primary aim of the visit was to verify the possibilities of a collaboration with Australia. The team was delighted with the way they were received by the employees of ANEL. Arjuna Natural Extracts Ltd (ANEL) is India’s leading company specialized in scientific methods of identification, separation and manufacturing of plant-based active compounds and Omega-3 fatty acids from marine and vegetable sources. ANEL also focuses on pharmacological evaluation of its products by design, monitoring and publishing of clinical studies for various applications in the dietary supplement, pharmaceutical, and cosmetic industries. BCM-95™, developed by ANEL scientists, has obtained six patents from the US and one from Japan; the European patent is pending.>
Arjuna extends Coimbatore plant
Arjuna Natural Extracts Limited inaugurated its Coimbatore plant on July 7, 2012. The entire Arjuna family visited the Coimbatore plant to be part of this auspicious occasion. The plant was inaugurated by P.J. Kunjachan, Managing Director of ANEL; Dr. Benny Antony, Director Technical, and P. J. Paul, Director of Operations. Employees of Arjuna gifted a memento to Dr. Benny Antony for being honoured as the 'Innovator of the Year' by the Spices Board of India. The management team also handed over educational scholarships to the deserved candidates of each department.>